McMullen Michael R.
Known title: DirectorCIK: 0001418949
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Agilent to acquire Proscia for up to $270M. Agilent Technologies has agreed to acquire digital pathology specialist Proscia in a deal valued at up to $270 million. The move is designed to strengthen Agilent's position in AI-enabled diagnostics and scientific intelligence. Following the announcement, TD Cowen raised its price target for the stock to $196.
Transaction History
| KLAC | ▲ Buy | Grant | 204 | $0 | 11/5/2025 | View on chart |
| KLAC | ▲ Buy | Grant | 350 | $0 | 11/6/2024 | View on chart |
| A | ▼ Sell | Open Market | 52,297 | $7.8M | 3/8/2024 | View on chart |
| A | ▲ Buy | Option Exercise | 2,751 | $116K | 12/13/2023 | View on chart |
| A | ▼ Sell | Open Market | 2,751 | $358K | 12/13/2023 | View on chart |
| A | ▼ Sell | Open Market | 62,467 | $8.1M | 12/7/2023 | View on chart |
| A | ▲ Buy | Option Exercise | 62,467 | $2.6M | 12/7/2023 | View on chart |
| A | ▲ Buy | Grant | 25,195 | $3.1M | 11/22/2023 | View on chart |
| A | ▼ Sell | Tax Withholding | 10,206 | $1.2M | 11/17/2023 | View on chart |
| A | ▼ Sell | Tax Withholding | 2,013 | $230K | 11/16/2023 | View on chart |
| A | ▼ Sell | Tax Withholding | 2,510 | $285K | 11/15/2023 | View on chart |
| A | ▲ Buy | Grant | 66,748 | $7.4M | 11/14/2023 | View on chart |
| A | ▼ Sell | Tax Withholding | 31,877 | $3.6M | 11/14/2023 | View on chart |
| KLAC | ▲ Buy | Grant | 493 | $0 | 11/1/2023 | View on chart |
| A | ▲ Buy | Option Exercise | 944 | $40K | 7/27/2023 | View on chart |
| A | ▼ Sell | Open Market | 944 | $123K | 7/27/2023 | View on chart |
| KLAC | ▲ Buy | Grant | 132 | $0 | 7/24/2023 | View on chart |
| A | ▲ Buy | Option Exercise | 128,726 | $5.3M | 11/22/2022 | View on chart |
| A | ▼ Sell | Open Market | 128,726 | $20.0M | 11/22/2022 | View on chart |
| A | ▼ Sell | Tax Withholding | 7,492 | $1.1M | 11/18/2022 | View on chart |
| A | ▼ Sell | Tax Withholding | 2,713 | $392K | 11/17/2022 | View on chart |
| A | ▲ Buy | Option Exercise | 6,775 | $276K | 11/16/2022 | View on chart |
| A | ▼ Sell | Open Market | 6,775 | $1.0M | 11/16/2022 | View on chart |
| A | ▼ Sell | Tax Withholding | 2,013 | $296K | 11/16/2022 | View on chart |
| A | ▼ Sell | Tax Withholding | 68,195 | $10.1M | 11/15/2022 | View on chart |
| A | ▲ Buy | Grant | 137,544 | $20.4M | 11/15/2022 | View on chart |
| A | ▲ Buy | Grant | 20,245 | $3.0M | 11/15/2022 | View on chart |
| A | ▼ Sell | Tax Withholding | 8,043 | $1.2M | 11/11/2022 | View on chart |
| A | ▲ Buy | Option Exercise | 6,775 | $276K | 11/9/2022 | View on chart |
| A | ▼ Sell | Open Market | 6,775 | $937K | 11/9/2022 | View on chart |
| A | ▲ Buy | Option Exercise | 6,775 | $276K | 11/2/2022 | View on chart |
| A | ▼ Sell | Open Market | 6,775 | $953K | 11/2/2022 | View on chart |
| A | ▼ Sell | Open Market | 6,775 | $911K | 10/26/2022 | View on chart |
| A | ▲ Buy | Option Exercise | 6,775 | $276K | 10/26/2022 | View on chart |
| A | ▲ Buy | Option Exercise | 6,775 | $276K | 10/19/2022 | View on chart |
| A | ▼ Sell | Open Market | 6,775 | $881K | 10/19/2022 | View on chart |
| A | ▼ Sell | Open Market | 123,459 | $18.4M | 12/20/2021 | View on chart |
| A | ▼ Sell | Tax Withholding | 7,493 | $1.2M | 11/19/2021 | View on chart |
| A | ▼ Sell | Tax Withholding | 2,713 | $438K | 11/17/2021 | View on chart |
| A | ▲ Buy | Grant | 16,240 | $2.6M | 11/16/2021 | View on chart |
| A | ▲ Buy | Grant | 136,087 | $22.0M | 11/16/2021 | View on chart |
| A | ▼ Sell | Tax Withholding | 75,497 | $12.2M | 11/16/2021 | View on chart |
| A | ▼ Sell | Tax Withholding | 5,260 | $846K | 11/12/2021 | View on chart |
| A | ▼ Sell | Tax Withholding | 8,043 | $1.3M | 11/12/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
KLAC noted for strong yearly gain and dividend quality
Recent articles have highlighted KLAC's 64.5% gain over the past year and its reputation as a dividend-quality stock. At the same time, broader chip‑equipment makers are experiencing losing streaks as AI spending concerns weigh on the sector. These factors together provide context for investors reviewing KLAC's performance and valuation.
KLAC noted for strong yearly gain and dividend quality. Recent articles have highlighted KLAC's 64.5% gain over the past year and its reputation as a dividend-quality stock. At the same time, broader chip‑equipment makers are experiencing losing streaks as AI spending concerns weigh on the sector. These factors together provide context for investors reviewing KLAC's performance and valuation.